Combining basal insulin analogs with glucagon-like peptide-1 mimetics.


Basal insulin analogs are recognized as an effective method of achieving and maintaining glycemic control for patients with type 2 diabetes. However, the progressive nature of the disease means that some individuals may require additional ways to maintain their glycemic goals. Intensification in these circumstances has traditionally been achieved by the… (More)
DOI: 10.1089/dia.2010.0250


  • Presentations referencing similar topics